SPRIFERMIN OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
Sprifermin (AS-902330) is a recombinant version of human fibroblast growth factor 18 (FGF18). Get more insights into Sprifermin Osteoarthritis pipeline report
TLC599 OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
TLC599 is a proprietary formulation of dexamethasone sodium phosphate (DSP) utilizing the BioSeizer technology. Read more about TLC599 Osteoarthritis report
WEGOVY OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
WEGOVY (Semaglutide) is a synthetic version of the human glucagon-like peptide-1 (GLP-1) hormone. Get more insights into WEGOVY Osteoarthritis pipeline report
X0002 OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
X0002, also known as ibuprofenamine hydrochloride spray, is an innovative transdermal non-steroidal anti-inflammatory drug. Read more about X0002 Osteoarthritis
ZILOSUL OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032
ZILOSUL is a semi-synthetic medication derived from the wood chips of European beech trees. Get more insights into our ZILOSUL Osteoarthritis pipeline report